利用表观遗传学:用于结直肠癌治疗的全基因组DNA甲基化试验

Chikashi Ishioka1

  • 1Department of Clinical Oncology, Tohoku University Graduate School of Medicine, and Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan; Department of Medical Oncology, JR Sendai Hospital, Sendai, Japan.

Cancer treatment reviews
|January 17, 2026
PubMed
概括

表观基因组生物标志物,特别是DNA甲基化,显示出预测结直肠癌治疗反应和预后的前景. 这篇评论强调了它们在个性化医学和先进诊断方面的潜力.